Humanin

Gene

Humanin is encoded in the mitochondrial genome by the 16S ribosomal RNA gene, MT-RNR2. Multiple paralogs are found in the nuclear genome (due to nuclear mitochondrial DNA segments) and are named MTRNR2L followed by a number. It is not entirely sure whether these paralogous isoforms are completely unexpressed.

Protein

The expressed peptide contains a three-turn α-helix, and has no symmetry.

The length of the peptide depends on where it is produced. If it is produced inside the mitochondria it will be 21 amino acids long. If it is produced outside the mitochondria, in the cytosol, it will be 24 amino acids long.

The full length 24 amino acid version of humanin has the sequence MAPRGFSCLLLLTSEIDLPVKRRA, with four residues cleaved from the C terminal end to form the 21 amino acid mitochondrial version MAPRGFSCLLLLTSEIDLPV. Several other natural isoforms are also known with slight variations to the amino acid sequence. Synthetic versions often have one or more amino acid changes to increase stability and improve activity, such as HNG with a S→G substitution at position 14, and HNGF6A which has an F→A substitution at position 6 as well. Humanin-glycine (HNG) is up to 1000x more potent than the natural version depending how the activity is assayed, and so is one of the more common synthetic analogues used in research and investigated for potential clinical applications. Shorter fragments such as HN(1-19) and HN(1-17) also retain some activity but are generally less potent.

Other species

Humanin is the most well-conserved of the mitochondria-derived peptides, found in such diverse species as humans, naked mole rats, and nematodes. Overexpression of humanin in Caenorhabditis elegans has been shown to extend the lifespan of that nematode by increasing autophagy.

The rat, Rattus norvegicus, has a gene, rattin (, "Humanin-like protein"), that encodes a 38 amino acid peptide homologous to humanin. The two genes produce cDNAs that show 88% sequence identity. The peptides are 81% identical, with the carboxyl terminal sequence in rattin being 14 amino acids longer than in humanin. Of the 24 amino acids in the rest of the rat sequence, 20 are identical to the amino acids in the human sequence.

The mouse MT-RNR2 humanin ortholog is a pseudogene, so no humanin is produced from the mtDNA. However, the nuclear genome harbors (like in humans) many copies of mitochondrial genomes, and one copy of the humanin homolog, Gm20594 (), is actively expressed.

Function

Humanin has several cytoprotective effects. Humanin and related peptides have antiinflammatory, immunomodulatory and neuroprotective effects and are of interest in the treatment of cardiovascular diseases such as atherosclerosis and heart failure, and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Interactions

Extracellular interaction with a tripartite receptor composed of gp130, WSX1, and CNTFR, as well as interaction with the formyl peptide receptor 2 (formylpeptide-like-1 receptor) have been published.

Intracellular interaction with BAX, tBID, IGFBP3, and TRIM11 may also be required for the effects of humanin.

Discovery

Humanin was the first mitochondria-derived peptide to be discovered. Humanin was independently found by three different labs looking at different parameters. The first to publish, in 2001, was the Nishimoto lab, which found humanin while looking for possible proteins that could protect cells from amyloid beta, a major component of Alzheimer's disease. The Reed lab found humanin when screening for proteins that could interact with Bcl-2-associated X protein (Bax), a major protein involved in apoptosis. The Pinchas Cohen lab independently discovered humanin when screening for proteins that interact with IGFBP3.

Research

Experiments using cultured cells have demonstrated that humanin has both neuroprotective as well as cytoprotective effects and experiments in rodents have found that it has protective effects in Alzheimer's disease models, Huntington's disease models and stroke models.

Humanin is proposed to have myriad neuroprotective and cytoprotective effects. Both studies in cells and rodents have both found that administration of humanin or humanin derivatives increases survival and/or physiological parameters in Alzheimer's disease models. In addition to Alzheimer's disease, humanin has other neuroprotective effects against models of Huntington's disease, prion disease, and stroke.

Beyond the possible neuroprotective effects, humanin protects against oxidative stress, atherosclerotic plaque formation, and heart attack. Humanin activates chaperone-mediated autophagy in a dose-dependent manner. Humanin decreases production of inflammatory cytokines, which is part of its anti-apoptotic effect. Metabolic effects have also been demonstrated and humanin helps improve survival of pancreatic beta-cells, which may help with type 1 diabetes, and increases insulin sensitivity, which may help with type 2 diabetes. In rats, the humanin analog appears to normalize glucose levels and reduce diabetes symptoms.

Rattin shows the same ability as humanin to defend neurons from the toxicity of beta-amyloid, associated with the degeneration in Alzheimer's disease.

References

References

1. (2021). "Protective Mechanism of Humanin Against Oxidative Stress in Aging-Related Cardiovascular Diseases". [[Frontiers in Endocrinology]].
2. (2020). "Mitochondria, immunosenescence and inflammaging: a role for mitokines?". Seminars in Immunopathology.
3. (2022). "Mitochondria-derived peptides in aging and healthspan". [[Journal of Clinical Investigation]].
4. (2023). "Mitochondrial stress and mitokines in aging". [[Aging Cell]].
5. (May 2001). "A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta". Proceedings of the National Academy of Sciences of the United States of America.
6. (October 2009). "Evidence for potential functionality of nuclearly-encoded humanin isoforms". Genomics.
7. (April 2005). "Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity". Biochemical and Biophysical Research Communications.
8. (February 2013). "The emerging role of the mitochondrial-derived peptide humanin in stress resistance". Journal of Molecular Endocrinology.
9. (May 2003). "Humanin peptide suppresses apoptosis by interfering with Bax activation". Nature.
10. (May 2001). "A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta". Proceedings of the National Academy of Sciences of the United States of America.
11. (June 2019). "Metabolomic profile of diet-induced obesity mice in response to humanin and small humanin-like peptide 2 treatment". Metabolomics.
12. "The Molecular Structure and Role of Humanin in Neural and Skeletal Diseases, and in Tissue Regeneration". Frontiers in Cell and Developmental Biology.
13. (December 2023). "Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives". Biology.
14. (August 2002). "A novel rat gene encoding a Humanin-like peptide endowed with broad neuroprotective activity". FASEB Journal.
15. (January 2021). "Expression Profile of Mouse Gm20594, Nuclear-Encoded Humanin-Like Gene". Journal of Lifestyle Medicine.
16. (November 2017). "Mitochondrially derived peptides as novel regulators of metabolism". The Journal of Physiology.
17. Kal S, Mahata S, Jati S, Mahata SK. Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives. ''Peptides''. 2024 Feb;172:171147. {{doi. 10.1016/j.peptides.2023.171147 {{pmid. 38160808
18. Li Y, Li Z, Ren Y, Lei Y, Yang S, Shi Y, Peng H, Yang W, Guo T, Yu Y, Xiong Y. Mitochondrial-derived peptides in cardiovascular disease: Novel insights and therapeutic opportunities. ''J Adv Res''. 2024 Oct;64:99-115. {{doi. 10.1016/j.jare.2023.11.018 {{pmid. 38008175
19. Moin H, Ashraf R, Butt B, Mustafa I, Shafiq M, Shah SAR. A Review on the Potential Role of Humanin Peptide and its Analogs in the Regulation of Autophagy Pathways for Therapeutic Application in Metabolic Disorders. ''Protein Pept Lett''. 2025;32(3):161-170. {{doi. 10.2174/0109298665363711250112050930 {{pmid. 39950467
20. Ran Y, Guo Z, Zhang L, Li H, Zhang X, Guan X, Cui X, Chen H, Cheng M. Mitochondria‑derived peptides: Promising microproteins in cardiovascular diseases. ''Mol Med Rep''. 2025 May;31(5):127. {{doi. 10.3892/mmr.2025.13492 {{pmid. 40084698
21. Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Fawzy MN, Papadakis M, Al-Botaty BM, Alruwaili M, El-Saber Batiha G. The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects. ''Eur J Pharmacol''. 2025 Jul 5;998:177510. {{doi. 10.1016/j.ejphar.2025.177510 {{pmid. 40090538
22. Patel K, Soni R, Shah J. The unexplored Nexus: Mitochondria derived microproteins and Parkinson's disease. ''Pathol Res Pract''. 2025 Sep;273:156136. {{doi. 10.1016/j.prp.2025.156136 {{pmid. 40694987
23. Thakur R, Chauhan A, Moudgil H, Singh S, Devi R. Mitochondrial-Derived Peptides: Implication in the Therapy of Neurodegenerative Diseases. ''Mol Neurobiol''. 2025 Dec;62(12):15871-15884. {{doi. 10.1007/s12035-025-05198-5 {{pmid. 40715951
24. (June 2009). "Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130". Molecular Biology of the Cell.
25. (June 2004). "Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor". Journal of Immunology.
26. (April 2005). "Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak". The Journal of Biological Chemistry.
27. (March 2003). "A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults". The European Journal of Neuroscience.
28. (October 2003). "Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis". Proceedings of the National Academy of Sciences of the United States of America.
29. (February 2013). "The emerging role of the mitochondrial-derived peptide humanin in stress resistance". Journal of Molecular Endocrinology.
30. (March 2005). "A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice". Journal of Neuroscience Research.
31. (December 2001). "Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults". The Journal of Neuroscience.
32. (2005). "Humanin attenuates apoptosis induced by DRPLA proteins with expanded polyglutamine stretches". Journal of Molecular Neuroscience.
33. (January 2004). "Humanin rescues cortical neurons from prion-peptide-induced apoptosis". Molecular and Cellular Neurosciences.
34. (October 2006). "Humanin is a novel neuroprotective agent against stroke". Stroke.
35. (November 2010). "Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress". Cardiovascular Research.
36. (November 2011). "Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice". Atherosclerosis.
37. (2012). "Humanin, a cytoprotective peptide, is expressed in carotid atherosclerotic [corrected] plaques in humans". PLOS ONE.
38. (October 2010). "Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice". Arteriosclerosis, Thrombosis, and Vascular Biology.
39. (March 2010). "The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice". Metabolism.
40. (July 2009). "Humanin: a novel central regulator of peripheral insulin action". PLOS ONE.
41. (March 2012). "New Clues to a Long Life".